全文获取类型
收费全文 | 413466篇 |
免费 | 32481篇 |
国内免费 | 11131篇 |
专业分类
耳鼻咽喉 | 3123篇 |
儿科学 | 11712篇 |
妇产科学 | 5356篇 |
基础医学 | 44307篇 |
口腔科学 | 7666篇 |
临床医学 | 37147篇 |
内科学 | 79401篇 |
皮肤病学 | 5435篇 |
神经病学 | 39765篇 |
特种医学 | 13206篇 |
外国民族医学 | 12篇 |
外科学 | 33763篇 |
综合类 | 54436篇 |
现状与发展 | 53篇 |
一般理论 | 20篇 |
预防医学 | 33508篇 |
眼科学 | 5470篇 |
药学 | 41371篇 |
236篇 | |
中国医学 | 23072篇 |
肿瘤学 | 18019篇 |
出版年
2024年 | 366篇 |
2023年 | 6771篇 |
2022年 | 9302篇 |
2021年 | 18314篇 |
2020年 | 17578篇 |
2019年 | 16274篇 |
2018年 | 16053篇 |
2017年 | 15931篇 |
2016年 | 15816篇 |
2015年 | 15155篇 |
2014年 | 24335篇 |
2013年 | 30140篇 |
2012年 | 23095篇 |
2011年 | 26218篇 |
2010年 | 18721篇 |
2009年 | 18275篇 |
2008年 | 19587篇 |
2007年 | 19879篇 |
2006年 | 18148篇 |
2005年 | 15944篇 |
2004年 | 13655篇 |
2003年 | 11996篇 |
2002年 | 9655篇 |
2001年 | 8549篇 |
2000年 | 7189篇 |
1999年 | 5939篇 |
1998年 | 4846篇 |
1997年 | 4573篇 |
1996年 | 4107篇 |
1995年 | 4051篇 |
1994年 | 3870篇 |
1993年 | 3245篇 |
1992年 | 3010篇 |
1991年 | 2784篇 |
1990年 | 2335篇 |
1989年 | 1938篇 |
1988年 | 1814篇 |
1987年 | 1648篇 |
1986年 | 1480篇 |
1985年 | 2344篇 |
1984年 | 2059篇 |
1983年 | 1425篇 |
1982年 | 1586篇 |
1981年 | 1320篇 |
1980年 | 1152篇 |
1979年 | 1000篇 |
1978年 | 726篇 |
1977年 | 616篇 |
1976年 | 566篇 |
1975年 | 455篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
991.
Amanda de Carvalho Dutra Lincoln Luís Silva Raíssa Bocchi Pedroso Yolande Pokam Tchuisseu Mariana Teixeira da Silva Marcela Bergamini Joo Felipe Hermann Costa Scheidt Pedro Henrique Iora Rogrio do Lago Franco Catherine Ann Staton Joo Ricardo Nickenig Vissoci Oscar Kenji Nihei Luciano de Andrade 《Global Heart》2021,16(1)
Background:No other disease has killed more than ischemic heart disease (IHD) for the past few years globally. Despite the advances in cardiology, the response time for starting treatment still leads patients to death because of the lack of healthcare coverage and access to referral centers.Objectives:To analyze the spatial disparities related to IHD mortality in the Parana state, Brazil.Methods:An ecological study using secondary data from Brazilian Health Informatics Department between 2013–2017 was performed to verify the IHD mortality. An spatial analysis was performed using the Global Moran and Local Indicators of Spatial Association (LISA) to verify the spatial dependency of IHD mortality. Lastly, multivariate spatial regression models were also developed using Ordinary Least Squares and Geographically Weighted Regression (GWR) to identify socioeconomic indicators (aging, income, and illiteracy rates), exam coverage (catheterization, angioplasty, and revascularization rates), and access to health (access index to cardiologists and chemical reperfusion centers) significantly correlated with IHD mortality. The chosen model was based on p < 0.05, highest adjusted R2 and lowest Akaike Information Criterion.Results:A total of 22,920 individuals died from IHD between 2013–2017. The spatial analysis confirmed a positive spatial autocorrelation global between IDH mortality rates (Moran’s I: 0.633, p < 0.01). The LISA analysis identified six high-high pattern clusters composed by 66 municipalities (16.5%). GWR presented the best model (Adjusted R2: 0.72) showing that accessibility to cardiologists and chemical reperfusion centers, and revascularization and angioplasty rates differentially affect the IHD mortality rates geographically. Aging and illiteracy rate presented positive correlation with IHD mortality rate, while income ratio presented negative correlation (p < 0.05).Conclusion:Regions of vulnerability were unveiled by the spatial analysis where sociodemographic, exam coverage and accessibility to health variables impacted differently the IHD mortality rates in Paraná state, Brazil.Highlights
- The increase in ischemic heart disease mortality rates is related to geographical disparities.
- The IHD mortality is differentially associated to socioeconomic factors, exam coverage, and access to health.
- Higher accessibility to chemical reperfusion centers did not necessarily improve patient outcomes in some regions of the state.
- Clusters of high mortality rate are placed in regions with low amount of cardiologists, income and schooling.
992.
993.
994.
995.
《Journal of vascular and interventional radiology : JVIR》2021,32(11):1606-1614
PurposeTo compare patients treated with large-volume paracentesis (LVP), transjugular intrahepatic portosystemic shunt (TIPS), and peritoneovenous shunt (PVS) for ascites.Materials and MethodsA retrospective study of 192 patients treated with LVP (94), TIPS (75), or PVS (23) was performed. Records were reviewed for patient characteristics and outcomes. The patients’ age differed (LVP, 59.5 years; TIPS, 58.8 years; and PVS, 65.6 years; P = .003). Nonalcoholic steatohepatitis was the most common etiology in the PVS cohort (11/23, 47%), and hepatitis C in the TIPS (27/75, 36%), and LVP cohorts (43/94, 46%) (P = .032). The model for end-stage liver disease score was significantly different (LVP, 14; TIPS, 13; and PVS, 8; P = .035). Hepatocellular carcinoma was higher in the PVS cohort (6/23 patients, 25%) than in the TIPS (4/75, 5%), and LVP (12/94, 12%) cohorts (P = .03).ResultsEmergency department visits and hospital readmissions were the highest in the LVP cohort (40%, ≥2 readmissions, P < .001). Patients required fewer LVPs after TIPS (1.5 to 0.14, P < .001) or PVS (2.1 to 0.5, P = .019). In an unadjusted Cox model, patients in the TIPS cohort were found to have a 58% reduction in the risk of death compared with patients in the LVP cohort (P = .003). Transplant-free survival (PVS, 44 days; TIPS, 155 days; and LVP, 213 days) differed (log rank = 0.001).ConclusionsThe survival in the PVS and TIPS cohorts was similar, with less healthcare utilization than the LVP cohort. PVS is a satisfactory alternative to LVP. 相似文献
996.
Rosai-Dorfman disease or sinus histiocytosis with lymphadenopathy is a rare benign histiocytic proliferative disorder of unknown etiology first described in 1969. It typically affects older females and most common presentation is with massive lymphadenopathy and nonspecific systemic symptoms; therefore, it is often confused with lymphoproliferative disorders [1, 2]. We present the case of a 69-year-old woman with nasal obstruction as only complaint. Laboratory tests showed normal leukocyte count with elevated ANC (absolute neutrophil count), normal RBC count with normal MCV (mean corpuscular volume) and MCH (mean corpuscular hemoglobin), elevated ESR (erythrocyte sedimentation rate), and normal IgG, IgA, and IgM values. Evaluation revealed a nasopharyngeal mass, which was biopsied and reported emperipolesis with positive CD68 and S-100; typical and differential findings of this disease [1, 2]. 18F FDG PET/CT was performed to determine the extent and involvement of the disease. Considering the presence of few symptoms and no significant laboratory abnormality, treating physicians decided to start a regimen of corticosteroids (prednisolone) for a period of 4 months, after which a follow-up with 18F FDG PET/CT will be performed. 相似文献
997.
Sarah Hallas Andrea Nelson Susan O'Meara Una Adderley Pauline Meskell Jane Nixon Aonghus O'Loughlin Sebastian Probst Wael Tawfick Thomas Wild Georgina Gethin 《Journal of tissue viability》2021,30(3):317-323
BackgroundA venous leg ulcer is a chronic leg wound caused by poor venous blood circulation in the lower limbs. It is a recurring condition causing pain, malodour, reduced mobility, and depression. Randomised controlled trials evaluating treatments for venous leg ulcers provide important evidence to inform clinical decision-making. However, for findings to be useful, outcomes need to be clinically meaningful, consistently reported across trials, and fully reported. Research has identified the large number of outcomes reported in venous leg ulcer trials, impacting both synthesis of results, and clinical decision-making. To address this, a core outcome set will be developed. A core outcome set is an agreed standardised set of outcomes which should be, as a minimum, measured and reported in all trials which evaluate treatment effectiveness for a given indication. A core outcome set has the potential to reduce research waste, improve the utility of RCTs, reduce reporting bias, facilitate treatment comparisons across different sources of evidence and expedite the production of systematic reviews, meta-analyses and evidence-based clinical guidelines.AimThe aim of this project is to develop a core outcome set for research evaluating the effectiveness of interventions for treating venous leg ulceration.MethodsThrough a scoping review of the literature on venous leg ulceration, we will firstly identify a list of candidate outcome domains (broad categories in relation to what is being measured) from randomised controlled trials and qualitative research, and outcomes (specific methods in relation to what is being measured). In two further stages, we will use the resulting lists of outcome domains and outcomes to design two online surveys. A range of stakeholders will be invited to participate in the surveys and they will be asked to indicate which outcome domains and outcomes are most important and should be considered as core in future research reports. 相似文献
998.
BackgroundPercutaneous-short segment screw fixation (SSSF) without bone fusion has proven to be a safe and effective modality for thoracolumbar spine fractures (TLSFs). When fracture consolidation is confirmed, pedicle screws are no longer essential, but clear indications for screw removal following fracture consolidation have not been established.MethodsIn total, we enrolled 31 patients with TLSFs who underwent screw removal following treatment using percutaneous-SSSF without fusion. Plain radiographs, taken at different intervals, measured local kyphosis using Cobb’ angle (CA), vertebra body height (VBH), and the segmental motion angle (SMA). A visual analogue scale (VAS) and the Oswestry disability index (ODI) were applied pre-screw removal and at the last follow-up.ResultsThe overall mean CA deteriorated by 1.58° (p < 0.05) and the overall mean VBH decreased by 0.52 mm (p = 0.001). SMA preservation was achieved in 18 patients (58.1%) and kyphotic recurrence occurred in 4 patients (12.9%). SMA preservation was statistically significant in patients who underwent screw removal within 12 months following the primary operation (p = 0.002). Kyphotic recurrence occurred in patients with a CA ≥ 20° at injury (p < 0.001) with a median interval of 16.5 months after screw removal. No patients reported worsening pain or an increased ODI score after screw removal.ConclusionScrew removal within 12 months can be recommended for restoration of SMA with improvement in clinical outcomes. Although, TLSFs with CA ≥ 20° at the time of injury can help to predict kyphotic recurrence after screw removal, the clinical outcomes are less relevant. 相似文献
999.
1000.